Cargando…

Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies

Detalles Bibliográficos
Autores principales: Lu, Xiaofan, Meng, Jialin, Su, Liwen, Jiang, Liyun, Wang, Haitao, Zhu, Junkai, Huang, Mengjia, Cheng, Wenxuan, Xu, Li, Ruan, Xinjia, Yeh, Shuyuan, Liang, Chaozhao, Yan, Fangrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693439/
https://www.ncbi.nlm.nih.gov/pubmed/34936229
http://dx.doi.org/10.1002/ctm2.601
_version_ 1784619143188709376
author Lu, Xiaofan
Meng, Jialin
Su, Liwen
Jiang, Liyun
Wang, Haitao
Zhu, Junkai
Huang, Mengjia
Cheng, Wenxuan
Xu, Li
Ruan, Xinjia
Yeh, Shuyuan
Liang, Chaozhao
Yan, Fangrong
author_facet Lu, Xiaofan
Meng, Jialin
Su, Liwen
Jiang, Liyun
Wang, Haitao
Zhu, Junkai
Huang, Mengjia
Cheng, Wenxuan
Xu, Li
Ruan, Xinjia
Yeh, Shuyuan
Liang, Chaozhao
Yan, Fangrong
author_sort Lu, Xiaofan
collection PubMed
description
format Online
Article
Text
id pubmed-8693439
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86934392022-01-04 Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies Lu, Xiaofan Meng, Jialin Su, Liwen Jiang, Liyun Wang, Haitao Zhu, Junkai Huang, Mengjia Cheng, Wenxuan Xu, Li Ruan, Xinjia Yeh, Shuyuan Liang, Chaozhao Yan, Fangrong Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-12-22 /pmc/articles/PMC8693439/ /pubmed/34936229 http://dx.doi.org/10.1002/ctm2.601 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Lu, Xiaofan
Meng, Jialin
Su, Liwen
Jiang, Liyun
Wang, Haitao
Zhu, Junkai
Huang, Mengjia
Cheng, Wenxuan
Xu, Li
Ruan, Xinjia
Yeh, Shuyuan
Liang, Chaozhao
Yan, Fangrong
Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
title Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
title_full Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
title_fullStr Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
title_full_unstemmed Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
title_short Multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
title_sort multi‐omics consensus ensemble refines the classification of muscle‐invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693439/
https://www.ncbi.nlm.nih.gov/pubmed/34936229
http://dx.doi.org/10.1002/ctm2.601
work_keys_str_mv AT luxiaofan multiomicsconsensusensemblerefinestheclassificationofmuscleinvasivebladdercancerwithstratifiedprognosistumourmicroenvironmentanddistinctsensitivitytofrontlinetherapies
AT mengjialin multiomicsconsensusensemblerefinestheclassificationofmuscleinvasivebladdercancerwithstratifiedprognosistumourmicroenvironmentanddistinctsensitivitytofrontlinetherapies
AT suliwen multiomicsconsensusensemblerefinestheclassificationofmuscleinvasivebladdercancerwithstratifiedprognosistumourmicroenvironmentanddistinctsensitivitytofrontlinetherapies
AT jiangliyun multiomicsconsensusensemblerefinestheclassificationofmuscleinvasivebladdercancerwithstratifiedprognosistumourmicroenvironmentanddistinctsensitivitytofrontlinetherapies
AT wanghaitao multiomicsconsensusensemblerefinestheclassificationofmuscleinvasivebladdercancerwithstratifiedprognosistumourmicroenvironmentanddistinctsensitivitytofrontlinetherapies
AT zhujunkai multiomicsconsensusensemblerefinestheclassificationofmuscleinvasivebladdercancerwithstratifiedprognosistumourmicroenvironmentanddistinctsensitivitytofrontlinetherapies
AT huangmengjia multiomicsconsensusensemblerefinestheclassificationofmuscleinvasivebladdercancerwithstratifiedprognosistumourmicroenvironmentanddistinctsensitivitytofrontlinetherapies
AT chengwenxuan multiomicsconsensusensemblerefinestheclassificationofmuscleinvasivebladdercancerwithstratifiedprognosistumourmicroenvironmentanddistinctsensitivitytofrontlinetherapies
AT xuli multiomicsconsensusensemblerefinestheclassificationofmuscleinvasivebladdercancerwithstratifiedprognosistumourmicroenvironmentanddistinctsensitivitytofrontlinetherapies
AT ruanxinjia multiomicsconsensusensemblerefinestheclassificationofmuscleinvasivebladdercancerwithstratifiedprognosistumourmicroenvironmentanddistinctsensitivitytofrontlinetherapies
AT yehshuyuan multiomicsconsensusensemblerefinestheclassificationofmuscleinvasivebladdercancerwithstratifiedprognosistumourmicroenvironmentanddistinctsensitivitytofrontlinetherapies
AT liangchaozhao multiomicsconsensusensemblerefinestheclassificationofmuscleinvasivebladdercancerwithstratifiedprognosistumourmicroenvironmentanddistinctsensitivitytofrontlinetherapies
AT yanfangrong multiomicsconsensusensemblerefinestheclassificationofmuscleinvasivebladdercancerwithstratifiedprognosistumourmicroenvironmentanddistinctsensitivitytofrontlinetherapies